eLaws | eCases | United States Code | Federal Courts |
Home » 2012 Issues » 77 FR (12/04/2012) » 2012-28784. Possession, Use, and Transfer of Select Agents and Toxins; Biennial Review

  2012-28784. Possession, Use, and Transfer of Select Agents and Toxins; Biennial Review  

  • Start Preamble

    AGENCY:

    Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

    ACTION:

    Final rule; correction.

    SUMMARY:

    The Department of Health and Human Services is correcting a final rule that appeared in the Federal Register on October 5, 2012 (77 FR 61084). The document updated the list of HHS and overlap biological agents and toxins and designated certain select agents and toxins as Tier 1 agents.

    DATES:

    Effective Date: Effective December 4, 2012.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Robbin Weyant, Director, Division of Select Agents and Toxins, Centers for Disease Control and Prevention, 1600 Clifton Rd., MS A-46, Atlanta, GA 30333. Telephone: (404) 718-2000.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In FR Doc. 2012-24389, published on October 5, 2012 (77 FR 61084) appearing on pages 61086 and 61110, the following corrections are made: Preamble [Corrected]

    1. On page 61086, in the second column, second paragraph, beginning on the fourth line, “According to available reports, Lujo virus (1) caused a fatal outbreak of hemorrhagic fever, (2) has a case fatality rate of 80 percent, (3) has been phylogenetically identified as an arenavirus, and (4) is related to those members of the Old World arenaviridae family (Junin, Machupo, Sabia, Guanarito, and Lassa) listed as HHS select agents that cause hemorrhagic fever and pose a significant risk to public health and safety (Ref 2)” is corrected to read: “According to available reports, Lujo virus (1) caused a fatal outbreak of hemorrhagic fever, (2) has a case fatality rate of 80 percent, (3) has been phylogenetically identified as an arenavirus, and (4) is related to those members of the Arenaviridae family (Junin, Machupo, Sabia, Guanarito, and Lassa) listed as HHS select agents that cause hemorrhagic fever and pose a significant risk to public health and safety (Ref 2).”

    [Corrected]

    2. On page, 61110, in the second column, in § 73.0 (Applicability and related requirements), in paragraph one, “All individuals and entities that possess SARS-CoV, Lujo virus, or Chapare virus must provide notice to CDC regarding their possession of SARS-CoV, Lujo virus, or Chapare virus on or before November 5, 2012. Currently registered individuals and entities possessing SARS-CoV, Lujo virus, or Chapare virus must meet all the requirements of this part by December 4, 2012. All previously unregistered individuals and entities possessing SARS-CoV, Lujo virus, or Chapare virus must meet all of the requirements of this part by April 3, 2013 is corrected to read: “All individuals and entities that possess SARS-CoV, Lujo virus, or Chapare virus must provide notice to CDC regarding their possession of SARS-CoV, Lujo virus, or Chapare virus on or before December 4, 2012. Currently registered individuals and entities possessing SARS-CoV, Lujo virus, or Chapare virus must meet all the requirements of this part by December 4, 2012. All previously unregistered individuals and entities possessing SARS-CoV, Lujo virus, or Chapare virus must meet all of the requirements of this part by April 3, 2013.”

    Start Signature

    Dated: November 21, 2012.

    Kathleen Sebelius,

    Secretary.

    End Signature End Supplemental Information

    [FR Doc. 2012-28784 Filed 12-3-12; 8:45 am]

    BILLING CODE 4163-18-P

Visit the Official Version
Leave a Comment

Document Information

Comments Received:
0 Comments
Published:
12/04/2012
Department:
Health and Human Services Department
Entry Type:
Rule
Action:
Final rule; correction.
Document Number:
2012-28784
Pages:
71702-71702 (1 pages)
RINs:
0920-AA34: Public Health Security and Bioterrorism Preparedness and Response Act of 2002; Biennial Review and Republication of the Select Agent and Toxin List
RIN Links:
https://www.federalregister.gov/regulations/0920-AA34/public-health-security-and-bioterrorism-preparedness-and-response-act-of-2002-biennial-review-and-re
PDF File:
2012-28784.pdf
Supporting Documents:
» Select Agent: Determination that Vaccine Strain, TC-83(A3G) of Venezuelan Equine Encephalitis Virus is a Regulated Strain of VEEV
» Order Suspending Introduction of Persons from a Country Where a Communicable Disease Exists
» World Trade Center Health Program: Petition 025-Parkinson's Disease and Parkinsonism, Including Heavy Metal-Induced Parkinsonism; Finding of Insufficient Evidence
» Guidelines for Determining the Probability of Causation Under the Energy Employees Occupational Illness Compensation Program Act
» World Trade Center Health Program: Petition 021-Deep Vein Thrombosis and Pulmonary Embolism; Finding of Insufficient Evidence
» World Trade Center Health Program: Petition 018-Hypertension; Finding of Insufficient Evidence
» Possession, Use, and Transfer of Select Agents and Toxins: Addition of Certain Influenza Virus Strains to the List of Select Agents and Toxins
» Foreign Quarantine Regulations, Proposed Revision of HHS/CDC Animal Importation Regulations
» Possession, Use, and Transfer of Select Agents and Toxins-Addition of Bacillus Cereus Biovar Anthracis to HHS List of Select Agents and Toxins
» Control of Communicable Diseases; Delay of Effective Date